• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右美托咪定诱导健康志愿者血管收缩的药代动力学和药效学。

Pharmacokinetics and pharmacodynamics of dexmedetomidine-induced vasoconstriction in healthy volunteers.

机构信息

University of California San Francisco, 500 Parnassus Avenue, MUE455, San Francisco, CA, 94143, USA.

University of Auckland, Private Bag 92024, Auckland, 1001, New Zealand.

出版信息

Br J Clin Pharmacol. 2018 Jun;84(6):1364-1372. doi: 10.1111/bcp.13571. Epub 2018 Apr 2.

DOI:10.1111/bcp.13571
PMID:29495085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5980451/
Abstract

AIMS

Alpha-2 agonists are direct peripheral vasoconstrictors, which achieve these effects by activating vascular smooth muscle alpha-2 adrenoceptors. The impact of this response during dexmedetomidine infusion remains poorly quantified. Our goal was to investigate the pharmacokinetic (PK) and pharmacodynamic (PD, vasoconstriction) effects of a computer-controlled dexmedetomidine infusion in healthy volunteers.

METHODS

After local ethics committee approval, we studied 10 healthy volunteers. To study the peripheral vasoconstrictive effect of dexmedetomidine without concurrent sympatholytic effects, sympathetic fibres were blocked with a brachial plexus block. Volunteers received a dexmedetomidine target-controlled infusion for 15 min, to a target concentration of 0.3 ng ml . Arterial blood samples were collected during and for 60 min after dexmedetomidine infusion for PK analysis. Peripheral vasoconstriction (PD) was assessed using finger photoelectric plethysmography. PK/PD analysis was carried out using nonlinear mixed-effect models.

RESULTS

We found that the computer-controlled infusion pump delivered mean concentrations greater than 0.3 ng ml over the 15-min infusion duration. The peripheral vasoconstrictive effect correlated with dexmedetomidine plasma concentrations during and after the infusion. A three-compartment model provided a better fit to the data than a two-compartment model.

CONCLUSIONS

We found that dexmedetomidine-induced vasoconstriction is concentration dependent over time. Dexmedetomidine PK were best estimated by a three-compartment model with allometric scaling. Our results may contribute to future modelling of dexmedetomidine-induced haemodynamic effects.

摘要

目的

α-2 激动剂是直接的外周血管收缩剂,通过激活血管平滑肌 α-2 肾上腺素能受体来实现这些作用。在右美托咪定输注期间,这种反应的影响尚未得到充分量化。我们的目标是研究健康志愿者中计算机控制的右美托咪定输注的药代动力学(PK)和药效学(PD,血管收缩)效应。

方法

在当地伦理委员会批准后,我们研究了 10 名健康志愿者。为了研究右美托咪定的外周血管收缩作用而不伴有同时的交感神经抑制作用,我们用臂丛神经阻滞来阻断交感神经纤维。志愿者接受右美托咪定目标控制输注 15 分钟,目标浓度为 0.3ng/ml。在右美托咪定输注期间和输注后 60 分钟内采集动脉血样进行 PK 分析。使用手指光电体积描记法评估外周血管收缩(PD)。使用非线性混合效应模型进行 PK/PD 分析。

结果

我们发现,在 15 分钟的输注过程中,计算机控制的输注泵输送的平均浓度超过了 0.3ng/ml。外周血管收缩作用与输注期间和输注后的右美托咪定血浆浓度相关。三房室模型比二房室模型提供了更好的拟合数据。

结论

我们发现,右美托咪定诱导的血管收缩随时间呈浓度依赖性。右美托咪定 PK 最好通过带有比例缩放的三房室模型进行估计。我们的结果可能有助于未来对右美托咪定引起的血液动力学效应的建模。

相似文献

1
Pharmacokinetics and pharmacodynamics of dexmedetomidine-induced vasoconstriction in healthy volunteers.右美托咪定诱导健康志愿者血管收缩的药代动力学和药效学。
Br J Clin Pharmacol. 2018 Jun;84(6):1364-1372. doi: 10.1111/bcp.13571. Epub 2018 Apr 2.
2
Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans.全身给药的α2激动剂在人体中引起外周血管收缩。
Anesthesiology. 2003 Jul;99(1):65-70. doi: 10.1097/00000542-200307000-00014.
3
Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.静脉注射右美托咪定在健康韩国受试者中的药代动力学和药效学。
J Clin Pharm Ther. 2012 Dec;37(6):698-703. doi: 10.1111/j.1365-2710.2012.01357.x. Epub 2012 May 31.
4
Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.新生儿及婴幼儿心脏直视手术后右美托咪定的药理学
Anesth Analg. 2016 May;122(5):1556-66. doi: 10.1213/ANE.0000000000000869.
5
Population Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Children Undergoing Ambulatory Surgery.儿童日间手术中右美托咪定的群体药代动力学和药效学。
Anesth Analg. 2018 Sep;127(3):716-723. doi: 10.1213/ANE.0000000000003413.
6
Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.右美托咪定的药代动力学和体外循环支持婴儿的新给药方案。
Anesth Analg. 2019 Dec;129(6):1519-1528. doi: 10.1213/ANE.0000000000003700.
7
Development of an Optimized Pharmacokinetic Model of Dexmedetomidine Using Target-controlled Infusion in Healthy Volunteers.利用健康志愿者靶控输注开发右美托咪定优化药代动力学模型。
Anesthesiology. 2015 Aug;123(2):357-67. doi: 10.1097/ALN.0000000000000740.
8
Effects of nitric oxide synthase inhibition on dexmedetomidine-induced vasoconstriction in healthy human volunteers.一氧化氮合酶抑制对健康人类志愿者中右美托咪定诱导的血管收缩的影响。
Br J Anaesth. 2009 Jan;102(1):38-46. doi: 10.1093/bja/aen316. Epub 2008 Nov 5.
9
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine.右美托咪定的临床药代动力学与药效学
Clin Pharmacokinet. 2017 Aug;56(8):893-913. doi: 10.1007/s40262-017-0507-7.
10
Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo.体内α1 和α2 肾上腺素能受体介导的血管收缩的独立调节。
J Hypertens. 2011 Feb;29(2):251-6. doi: 10.1097/HJH.0b013e3283407ffd.

引用本文的文献

1
Changes in brain connectivity and neurovascular dynamics during dexmedetomidine-induced loss of consciousness.右美托咪定诱导意识丧失期间脑连接性和神经血管动力学的变化。
Commun Biol. 2025 Aug 20;8(1):1254. doi: 10.1038/s42003-025-08577-9.
2
Effect of vasoconstriction by dexmedetomidine in the mandible of rat.右美托咪定在下颌骨中对大鼠血管收缩的影响。
J Dent Anesth Pain Med. 2024 Dec;24(6):375-383. doi: 10.17245/jdapm.2024.24.6.375. Epub 2024 Nov 26.
3
A systematic review of dexmedetomidine pharmacology in pediatric patients.小儿患者右美托咪定药理学的系统评价
Clin Transl Sci. 2024 Dec;17(12):e70020. doi: 10.1111/cts.70020.
4
Moderate Sedation or Deep Sedation for ERCP: What Are the Preferences in the Literature?内镜逆行胰胆管造影术(ERCP)的适度镇静或深度镇静:文献中的偏好是什么?
Life (Basel). 2024 Oct 15;14(10):1306. doi: 10.3390/life14101306.
5
Changes in brain connectivity and neurovascular dynamics during dexmedetomidine-induced loss of consciousness.右美托咪定诱导意识丧失期间脑连接性和神经血管动力学的变化。
bioRxiv. 2024 Nov 12:2024.10.04.616650. doi: 10.1101/2024.10.04.616650.
6
Target-controlled infusion - Past, present, and future.靶控输注——过去、现在与未来。
J Anaesthesiol Clin Pharmacol. 2024 Jul-Sep;40(3):371-380. doi: 10.4103/joacp.joacp_64_23. Epub 2023 Aug 16.
7
Efficacy of Pre-emptive Infiltration of Dexmedetomidine with a Local Anaesthetic on Postoperative Pain in Maxillofacial Trauma Management under General Anaesthesia: A Prospective Study.在全身麻醉下,右美托咪定与局部麻醉药预先浸润用于颌面部创伤管理中对术后疼痛的疗效:一项前瞻性研究。
Ann Maxillofac Surg. 2024 Jan-Jun;14(1):33-39. doi: 10.4103/ams.ams_225_23. Epub 2024 May 8.
8
Perioperative Hypotension in Patients Undergoing Orthopedic Upper Extremity Surgery with Dexmedetomidine Sedation: A Retrospective Study.右美托咪定镇静下接受上肢骨科手术患者围手术期低血压:一项回顾性研究
J Pers Med. 2023 Nov 28;13(12):1658. doi: 10.3390/jpm13121658.
9
Determination of the effective dose of dexmedetomidine to achieve loss of consciousness during anesthesia induction.确定麻醉诱导期间达到意识消失的右美托咪定有效剂量。
Front Med (Lausanne). 2023 Apr 20;10:1158085. doi: 10.3389/fmed.2023.1158085. eCollection 2023.
10
Justification Of Empiric Methodology to Determine Dexmedetomidine Dose for the TREX Study.用于确定TREX研究中右美托咪定剂量的经验性方法的依据。
Paediatr Anaesth. 2022 Nov 17;33(3):236-42. doi: 10.1111/pan.14605.

本文引用的文献

1
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.2018 年 IUPHAR/BPS 药理学指南:更新和扩展,以包含新的免疫药理学指南。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. doi: 10.1093/nar/gkx1121.
2
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors.《药理学 2017/18 简明指南:G 蛋白偶联受体》
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S17-S129. doi: 10.1111/bph.13878.
3
Infusions Are the Optimal Dosing Method in Intravenous ADME Studies Rather Than Bolus Dosing.在静脉药物代谢动力学研究中,输注是最佳给药方法,而非推注给药。
J Clin Pharmacol. 2018 Jan;58(1):25-28. doi: 10.1002/jcph.991. Epub 2017 Aug 16.
4
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine.右美托咪定的临床药代动力学与药效学
Clin Pharmacokinet. 2017 Aug;56(8):893-913. doi: 10.1007/s40262-017-0507-7.
5
Development of an Optimized Pharmacokinetic Model of Dexmedetomidine Using Target-controlled Infusion in Healthy Volunteers.利用健康志愿者靶控输注开发右美托咪定优化药代动力学模型。
Anesthesiology. 2015 Aug;123(2):357-67. doi: 10.1097/ALN.0000000000000740.
6
A two-compartment effect site model describes the bispectral index after different rates of propofol infusion.双室效应部位模型描述了不同丙泊酚输注速率后的脑电双频指数。
J Pharmacokinet Pharmacodyn. 2010 Jun;37(3):243-55. doi: 10.1007/s10928-010-9157-1. Epub 2010 Apr 23.
7
Dexmedetomidine hemodynamics in children after cardiac surgery.心脏手术后儿童的右美托咪定血流动力学
Paediatr Anaesth. 2010 May;20(5):425-33. doi: 10.1111/j.1460-9592.2010.03285.x. Epub 2010 Mar 11.
8
Effects of nitric oxide synthase inhibition on dexmedetomidine-induced vasoconstriction in healthy human volunteers.一氧化氮合酶抑制对健康人类志愿者中右美托咪定诱导的血管收缩的影响。
Br J Anaesth. 2009 Jan;102(1):38-46. doi: 10.1093/bja/aen316. Epub 2008 Nov 5.
9
Extensions to the visual predictive check to facilitate model performance evaluation.视觉预测检查的扩展,以促进模型性能评估。
J Pharmacokinet Pharmacodyn. 2008 Apr;35(2):185-202. doi: 10.1007/s10928-007-9081-1. Epub 2008 Jan 16.
10
Mechanism-based concepts of size and maturity in pharmacokinetics.药代动力学中基于机制的大小和成熟度概念。
Annu Rev Pharmacol Toxicol. 2008;48:303-32. doi: 10.1146/annurev.pharmtox.48.113006.094708.